Cargando…
Non‐coding RNAs in cardiac hypertrophy
Heart failure is one of the largest contributors to disease burden and healthcare outflow in the Western world. Despite significant progress in the treatment of heart failure, disease prognosis remains very poor, with the only curative therapy still being heart transplantation. To counteract the cur...
Autores principales: | Ottaviani, Lara, da Costa Martins, Paula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471409/ https://www.ncbi.nlm.nih.gov/pubmed/28233323 http://dx.doi.org/10.1113/JP273129 |
Ejemplares similares
-
Hypertension‐induced remodelling: on the interactions of cardiac risk factors
por: Tomek, Jakub, et al.
Publicado: (2017) -
Raf kinase inhibitor protein: lessons of a better way for β‐adrenergic receptor activation in the heart
por: Lorenz, Kristina, et al.
Publicado: (2017) -
Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction
por: Yamanaka, Shinsuke, et al.
Publicado: (2020) -
Non-coding RNAs in neuropathic pain
por: Kalpachidou, Theodora, et al.
Publicado: (2020) -
Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)